Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


FlowSyn™ Maxi from Uniqsis – Scaling up your flow chemistry experiments has never been easier!

Product Image
Product Description

Increase your productivity to 5 kg+ per day with the FlowSyn™ Maxi from Uniqsis!

The FlowSyn Maxi is a versatile and highly productive continuous flow reactor for high throughput single reactions with two reagents. With a flow rate of up to 80 ml/ min and the option to use Uniqsis’ high capacity (60 ml) coil reactor, the FlowSyn Maxi is the ideal scale-up tool for increasing your output to multi kg per day.

The high resolution FlowSyn user interface quickly guides you through the process of setting up your desired flow chemistry reactions. Once set up, the system automatically runs the experiment and cleans itself at the end of the program cycle. Comprehensive safety features, including automatic pressure regulation and over-pressure shut-down, ensure safe operation at all times.

With its key flowpath components made of stainless steel, the FlowSyn Maxi is a highly robust system capable of operating at 260°C, 1400 psi, and withstanding contact with corrosive fluids such as sulphuric and nitric acid. Other flowpath options (such as Hastelloy® and PTFE) are available for maximum chemical compatibility.

Uniqsis offers extensive “plug and play” options for temperature controlled static mixers and coil reactors, including the FlowSyn 60 ml coil reactor kit specifically designed for scale up.

The high-throughput FlowSyn Maxi can be expanded with the Uniqsis Binary Pump Module (BPM) to provide 4 reagent inputs and with other FlowSyn modules for automated multi-experiment and multi-step combinatorial capability. Optional cooling modules, with cooling capacities down to -88°C, are available for controlling highly exothermic reactions.

If you are looking at improving the output of your flow chemistry experiments, consider the FlowSyn Maxi from Uniqsis. Scale-up has never been easier!

Uniqsis-FlowSyn-Maxi.gif

UniqsisFlowSynMaxiSecImage.gif

Product FlowSyn™ Maxi from Uniqsis – Scaling up your flow chemistry experiments has never been easier!
Company Uniqsis
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Uniqsis
29 Station Road Shepreth Cambridgeshire SG8 6GB UK

Tel: +44 (0)845 864 7747

Email: info@uniqsis.com



Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!